Investing in tomorrow's success

about 819 Capital Partners

819 Capital Partners is a dynamic and forward-thinking investment firm specializing in venture capital, private equity, and corporate finance. Our mission is to drive innovation, growth and value creation for our partners through a diverse portfolio of investments, positively impacting key sectors.

About us

Expertise to realise growth and maximise value

€85M+

Total AUM

Venture, Growth, Control, Buy-and-build

Transaction type

42

Portfolio companies

€500M+

Revenues active investments

1,000+

Portfolio employees

Portfolio

View all

Our news

March 6, 2026

819 Capital Partners acquires key assets of Lead Pharma, enabling continuation of operations

Deventer, 6 March 2026 - 819 Capital Partners has acquired the key assets of Lead Pharma, thereby realizing a continuation based on the company’s patent portfolio and associated research programs. The transaction includes intellectual property rights, research data, and selected development programs. Lead Pharma develops innovative small-molecule medicines for the treatment of cancer and autoimmune diseases. Over the past years, the company built a strong research platform and multiple drug candidates, collaborating with international pharmaceutical companies...

Continue reading
February 10, 2026

819 Capital Partners acquires Chalet.nl

Deventer, 10 February 2026 – 819 Capital Partners announces the acquisition of Chalet.nl, a well-established Dutch touroperator that has been a leading authority in winter sports holidays for more than 25 years. Chalet.nl specializes in the organization and rental of chalets and apartments in leading winter sports destinations across France, Austria, Switzerland and Italy. The company has built a strong online presence and is known for its reliable service, personal approach, and deep expertise in...

Continue reading